Showing 10,166 results

Filters Content type: News, Editors' picks, About HIV Topic: Health services & systems

Getting the most from doctors, nurses, pharmacists and other healthcare providers.

Access to healthcare

Lenacapavir, the revolutionary HIV drug, still hasn’t reached Latin America

Editor's pick
El País
5 August 2026
Antibody-based prevention

As a weekly anti-HIV pill nears the market, vaccine research faces new hurdles

Editor's pick
Science
5 August 2026
Migrants, refugees & displaced people

Zimbabweans Fleeing Xenophobia in South Africa Battle to Get HIV Medicine Back Home

Editor's pick
Health Policy Watch
5 August 2026
Injectable & long-acting PrEP

Gilead’s HIV PrEP franchise hits $1B quarterly sales, but analysts question Yeztugo durability

Editor's pick
FiercePharma
5 August 2026
Access to healthcare

South Africa: Some pieces falling into place for monthly HIV prevention pill, but key data not yet in

Editor's pick
Spotlight
2 August 2026
Access to healthcare

Why is Latin America still waiting for long-acting HIV prevention?

Editor's pick
Devex (requires free registration)
2 August 2026
Access to healthcare

Brazil: MSF at AIDS 2026 demanding affordable access to lenacapavir everywhere

Editor's pick
Médecins Sans Frontières
2 August 2026
Finance & funding

Global Activists Protest French Ambassador for Global Health Anne-Claire Amprou at the 26th International AIDS Conference

Editor's pick
Health GAP (Global Access Project)
2 August 2026
Finance & funding

Brazil’s HIV advocates say they predicted USAID funding cuts: ‘We would see the trends’

Editor's pick
The Guardian
2 August 2026
Global health initiatives

New US HIV agreements leave civil society and key populations on the sidelines

News
1 August 2026
People who inject drugs

Fiji’s perfect HIV storm

News
1 August 2026
Finance & funding

Adjusting to a Post-PEPFAR World

Editor's pick
Health Policy Watch
31 July 2026
Finance & funding

PEPFAR cuts close key population services and accelerate decline in children's HIV treatment

News
31 July 2026
Economic & social inequality

Water insecurity nearly quadruples odds of poor HIV outcomes, while hunger and partner violence compound risk in East Africa

News
29 July 2026
Injectable & long-acting PrEP

Monthly PrEP pill could be made for US$3 a year, but Latin America is shut out of generic licensing

News
29 July 2026
Injectable & long-acting PrEP

Nearly 200,000 lenacapavir shots given across Africa, but supply issues pose challenges

News
29 July 2026
Access to healthcare

Countries in Latin America and the Caribbean helped build the future of HIV prevention. But will they be able to benefit from it?

Editor's pick
Unitaid
27 July 2026
Conference announcements & declarations

An Inside Look at the AIDS 2026 Clinical Agenda

Editor's pick
TheBodyPro
27 July 2026
Pharmaceutical industry

Oil price shocks could raise the cost of HIV medicines by up to 44%, Unitaid analysis finds

Editor's pick
Unitaid
27 July 2026
Access to healthcare

Activists React to Merck’s Voluntary License for Generic Production of Investigational Long-Acting Oral PrEP Product, Alimatravir

Editor's pick
Health GAP (Global Access Project)
27 July 2026
Injectable & long-acting PrEP

This drug could help end the HIV epidemic. Its rollout has hit speed bumps

Editor's pick
Science
27 July 2026
Global health initiatives

Amid Row Over Exclusion, US Concedes that HIV Approach Needs to Include ‘All People at Risk’

Editor's pick
Health Policy Watch
27 July 2026
Government, leadership & policy

The US State Department Redraws the Map of Africa at the AIDS2026 Conference

Editor's pick
To End a Plague ... Again
27 July 2026
Government, leadership & policy

AIDS 2026: Activists challenge US Government’s claims to manage PEPFAR

Editor's pick
i-Base
27 July 2026